Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Cumberland Pharmaceuticals Inc. CPIX
$1.67
-$0.05 (-2.91%)
На 18:01, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
24472180.00000000
-
week52high
2.91
-
week52low
1.60
-
Revenue
42010949
-
P/E TTM
-4
-
Beta
0.33910000
-
EPS
-0.37000000
-
Last Dividend
0.00000000
-
Next Earnings Date
09 мая 2023 г. в 20:00
Описание компании
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of chronic and acute constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It also develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Further, it develops a clinical program for the use of ifetroban to treat progressive fibrosing interstitial lung diseases; and a product candidate that is in Phase II clinical trial for cholesterol reducing agent to use in the hospital setting. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| B. Riley | Buy | Buy | 03 дек 2019 г. |
| B. Riley FBR | Buy | Buy | 18 ноя 2019 г. |
| B. Riley FBR | Buy | Buy | 17 авг 2018 г. |
| B. Riley FBR | Buy | 05 мая 2018 г. | |
| B. Riley FBR | Buy | 17 апр 2018 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Jones James | A | 26293 | 88 | 21 дек 2022 г. |
| Galante Joseph C | A | 57356 | 180 | 21 дек 2022 г. |
| Krogulski Kenneth | A | 204955 | 360 | 21 дек 2022 г. |
| Young Caroline | A | 19587 | 109 | 20 дек 2022 г. |
| Jones James | A | 26205 | 121 | 20 дек 2022 г. |
| Galante Joseph C | A | 57176 | 200 | 20 дек 2022 г. |
| Krogulski Kenneth | A | 204595 | 370 | 20 дек 2022 г. |
| Young Caroline | A | 19478 | 30 | 19 дек 2022 г. |
| Jones James | A | 26084 | 70 | 19 дек 2022 г. |
| Galante Joseph C | A | 56976 | 250 | 19 дек 2022 г. |
Новостная лента
Cumberland Pharmaceuticals Inc. (CPIX) Q4 2022 Earnings Call Transcript
Seeking Alpha
07 мар 2023 г. в 22:47
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX ) Q4 2022 Earnings Conference Call March 7, 2023 4:30 PM ET Company Participants Molly Aggas - Account Supervisor, Dalton Agency A.J. Kazimi - CEO Todd Anthony - VP, Organizational Development John Hamm - CFO Conference Call Participants Operator Good afternoon, and welcome to Cumberland Pharmaceuticals' 2022 Financial Report and Company Update.
Cumberland Pharmaceuticals, Inc. (CPIX) Q3 2022 Earnings Call Transcript
Seeking Alpha
12 ноя 2022 г. в 20:53
Cumberland Pharmaceuticals, Inc. (NASDAQ:CPIX ) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Molly Aggas - Account Supervisor, Dalton Agency A. J. Kazimi - Founder, Chairman, President & CEO John Hamm - Senior Director of Finance & Accounting & CFO Conference Call Participants Operator Good afternoon, and welcome to Cumberland Pharmaceuticals' Third Quarter 2022 Financial Report and Company Update.
Cumberland Pharmaceuticals Inc. (CPIX) CEO A.J. Kazimi on Q2 2022 Results - Earnings Call Transcript
Seeking Alpha
13 авг 2022 г. в 14:07
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX ) Q2 2022 Results Conference Call August 9, 2022 4:30 PM ET Company Participants Molly Aggas - Account Supervisor, Dalton Agency A.J. Kazimi - Chief Executive Officer Todd Anthony - Vice President, Organizational Development John Hamm - Chief Financial Officer Operator Good afternoon, and welcome to Cumberland Pharmaceuticals Second Quarter 2022 Financial Report and Company Update.
Cumberland Pharmaceuticals Inc. (CPIX) CEO A.J. Kazimi on Q1 2022 Results - Earnings Call Transcript
Seeking Alpha
14 мая 2022 г. в 17:42
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX ) Q1 2022 Results Earnings Conference Call May 10, 2022 4:30 PM ET Company Participants Molly Aggas - Account Supervisor, Dalton Agency A.J. Kazimi - Chief Executive Officer Todd Anthony - Vice President, Organizational Development John Hamm - Chief Financial Officer Operator Good afternoon, and thank you for joining Cumberland Pharmaceuticals First Quarter 2022 Financial Report and Company Update.